A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Clinical trial NCT06213038 · RECRUITING
Trial details
- NCT number
- NCT06213038
- Sponsor
- Youxin Chen
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-05
- Primary completion
- 2025-05-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.